UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006340 |
|---|---|
| Receipt number | R000007519 |
| Scientific Title | Phase III study comparing gefitinib with gefitinib combined with carboplatin/pemetrexed for advanced non-small cell lung cancer with EGFR mutation (NEJ009) |
| Date of disclosure of the study information | 2011/10/01 |
| Last modified on | 2019/09/19 09:21:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/09/13 16:41:22 | ||
| 2 | Update | 2012/10/12 10:22:59 | Recruitment status |
|
| 3 | Update | 2013/09/13 09:14:54 | TEL Last name of contact person Last name of contact person Address Address |
|
| 4 | Update | 2015/01/30 17:26:57 | Recruitment status |
|
| 5 | Update | 2016/04/12 12:31:00 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes |
|
| 6 | Update | 2016/09/16 18:30:55 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 7 | Update | 2016/09/16 18:35:23 | Randomization unit Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 8 | Update | 2019/09/19 09:15:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2019/09/19 09:17:17 | Number of participants that the trial has enrolled |
|
| 10 | Update | 2019/09/19 09:21:20 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
